Avalon Capital Management’s ProShares Ultra Health Care RXL Stock Holding History

Avalon Capital Management’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-32,772	Closed	-$702K	–	68
2018 Q1	$702K	Sell	32,772 -8,272	-20%	-$192K	0.69%	37
2017 Q4	$905K	Buy	+41,044	New	+$892K	0.81%	40

Other funds holding RXL

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

BRC

Bell Rock Capital Rehoboth Beach, Delaware $81M AUM 9.85% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

RPG

Risk Paradigm Group Austin, Texas $117M AUM

Avalon Capital Management's RXL Position: Q2 2018 in Review

Avalon Capital Management sold out of ProShares Ultra Health Care (RXL) in Q2 2018, closing a stake of 32,772 shares — an estimated $702K sold.

Avalon Capital Management first reported a position in RXL in Q4 2017 and held it in 2 quarters. The position peaked at $905K in Q4 2017. 18 funds tracked by Wall St. Rank hold RXL as of Q2 2018.

Avalon Capital Management reported no remaining ProShares Ultra Health Care position as of Q2 2018 after selling out during the quarter.
Avalon Capital Management sold 32,772 ProShares Ultra Health Care shares in Q2 2018, an estimated $702K.
Avalon Capital Management first reported a position in ProShares Ultra Health Care in Q4 2017 and held it in 2 quarters.
Avalon Capital Management's ProShares Ultra Health Care position peaked at $905K in Q4 2017.
18 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2018.

Based on Avalon Capital Management's 13F filing for Q2 2018, filed 19 Jul 2018.